Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 17pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5789189: Inhibition of cyst formation by cytoskeletal specific drugs
[ Derwent Title ]
>> View Certificate of Correction for this publication


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
17 pages

 
Inventor: Woo, David D. L.; Los Angeles, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 1998-08-04 / 1995-05-22

Application Number: US1995000406910

IPC Code: Advanced: C12N 5/06; G01N 33/50;
Core: more...
IPC-7: C12N 5/00; C12Q 1/02; C12Q 1/10; C12Q 1/24;

ECLA Code: C12N5/06B12K; G01N33/50D2;

U.S. Class: Current: 435/030; 435/004; 435/029; 435/039; 435/041; 435/354; 435/383; 435/395; 436/063; 514/462; 514/629; 540/478; 549/345;
Original: 435/030; 435/029; 435/039; 435/004; 435/240.2; 435/240.23; 435/041; 436/063; 514/462; 514/629; 540/004.78; 549/345;

Field of Search: 435/030,29,39,4,41,240.2,240.23 436/063,64,74 514/352,462,629 530/350 540/478 549/345

Government Interest:

STATEMENT OF UNITED STATES GOVERNMENT SUPPORT
    Certain aspects of this invention were made with United States government funding under NIH Grant No. DK 40700. The United States government has certain rights in these aspects of the invention in the United States.

Priority Number:
1995-05-22  US1995000406910
1993-09-24  WO1993US0009124

Abstract:     The invention provides a method of producing a culture of polycystic kidney cells which form cysts in vitro. A cell culture of polycystic kidney cells is also provided. A method for screening an agent in vitro to determine the effectiveness of the agent in treating polycystic kidney disease is disclosed. Further, a method of treating a mammal having polycystic kidney disease by administering a pharmaceutical composition is provided.

Attorney, Agent or Firm: Knobbe Martens Olson & Bear, LLP ;

Primary / Asst. Examiners: Leary, Louise;

Maintenance Status: CC Certificate of Correction issued
View Certificate of Correction

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AU CA EP JP US  DE ES FR GB IT 

Family: Show 6 known family members

First Claim:
Show all 27 claims
What is claimed is:     1. A method of producing a culture of polycystic kidney cells which form cysts in vitro, comprising:
  • preparing a suspension of polycystic kidney cells that form cysts in vivo in a medium suitable for the maintenance of said cells; and
  • culturing said cells on a solid phase which substantially prevents the formation of a layer of said cells on the surface of said solid phase.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

PCT Number: PCT/US93/09124    WO9408041

PCT Pub./Filed Dates: 1994-04-14 / 1993-09-24

§ 371 / 102(e) Dates: 1995-05-22 / 1995-05-22

Forward References: Show 5 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (5)   |   Backward references (7)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 9pp US4853221  1989-08 Elslager et al.  Warner-Lambert Company Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
Buy PDF- 11pp US4870162  1989-09 Trovet et al.  Omnichem Conjugates of vinblastine, a process for their preparation and their use in therapy
Buy PDF- 9pp US4882314  1989-11 Takeuchi et al.  Kenkyusho; Rikagaku A composition and method of treating selected malignant conditions
Buy PDF- 11pp US4983636  1991-01 Takeuchi et al.  Rikagaku Kenkyusho Wako Composition and method of treating selected malignant conditions
Buy PDF- 6pp US5124338  1992-06 King  Burroughs Wellcome Company Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
Buy PDF- 10pp US5352805  1994-10 Kingston et al.  Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
Buy PDF- 18pp US5455161  1995-10 Assaraf et al.  Technicon Reseach & Development Foundation Ltd. Method for the monitoring of multiple anticancer drug resistance
       
Foreign References: None

Other Abstract Info: CHEMABS 121(07)073915D DERABS C1994-135601

Other References:
  • Siegal, et al., Transplantation; vol. 54, No. 3; 1992; p. 1131; The polycystic kidney donor. Month not available. (1 pages) Cited by 2 patents [ISI abstract]
  • Merck & Co., Budavari, S.Ed.: The Merck Index; 1989; p. 1435. Month not available.
  • Woo; Journal of American Society of Nephrology; vol. 3, No. 3, 1992; p. 302; Cytoskeletal specific drugs inhibit in-vitro cyst formation. Month not available.
  • Ravia, et al.; Human Genetics; vol. 71, No. 4, 1985; pp. 294-300; Differences between cystic fibrosis and normal cells in the degree of satelite association. Month not available. (7 pages) Cited by 2 patents
  • Forrest; Biochemical and Biophysical Research Communications; vol. 98, No. 1; Jan. 15, 1981; pp. 324-329; Colchicine Binding activity and Tyrosyl tubulin ligase activity in normal and cystic fibrosis fibroblasts.
  • Rubino et al, Europ J Cell Biology, vol. 30, pp. 182-190 (1983). Month no available. (9 pages) Cited by 2 patents


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help